Results 1 to 10 of about 81,608 (302)

Malignant Pleural Mesothelioma [PDF]

open access: yesJournal of Clinical Oncology, 2009
Malignant pleural mesothelioma continues to be a challenge. The diagnosis and treatment of patients with malignant pleural mesothelioma requires a multidisciplinary approach. The diagnosis is best made by thoracoscopic biopsy and the aid of immunohistochemistry. Molecular studies identified inactivation of the neurofibromatosis-2 gene and INK4alpha/ARF
Anne S Tsao
exaly   +8 more sources

Malignant mesothelioma [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2008
Malignant mesothelioma is a fatal asbestos-associated malignancy originating from the lining cells (mesothelium) of the pleural and peritoneal cavities, as well as the pericardium and the tunica vaginalis.
Parker Robert J   +2 more
doaj   +3 more sources

Case report: A1159T mutation in malignant peritoneal mesothelioma may be associated with tumor recurrence

open access: goldSAGE Open Medical Case Reports
Malignant peritoneal mesothelioma is an exceedingly rare malignant tumor. Herein, we present a case of malignant peritoneal mesothelioma in a 59-year-old Chinese female patient who was stable after treatment for multiple relapses.
Ying Li   +7 more
doaj   +2 more sources

Malignant Mesothelioma [PDF]

open access: yesCancers, 2021
Malignant mesothelioma (MM) is a rare and aggressive cancer, related to chronic inflammation and oxidative stress caused mainly by exposure to asbestos [...]
Daniel L. Pouliquen, Joanna Kopecka
openaire   +3 more sources

Malignant Mesothelioma [PDF]

open access: yesJournal of the Royal Society of Medicine, 1989
Mesothelioma is a malignant tumour of the pleura or peritoneum caused by asbestos. It is increasing in frequency and the prognosis remains grim, with average survival around 1 year.Medical literature and personal experience.Amphibole fibres are far more potent than chrysotile in causing mesothelioma.A minority view suggests that mesotheliomas in those ...
Arthur I. Spriggs, Michael M. Boddington
openaire   +5 more sources

Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Promotes Cell Proliferation of Malignant Mesothelioma Cells by Downregulating p27Kip1

open access: yesFrontiers in Oncology, 2022
Malignant mesothelioma is a tumor with a poor prognosis, mainly caused by asbestos exposure and with no adequate treatment yet. To develop future therapeutic targets, we analyzed the microarray dataset GSE 29370 of malignant mesothelioma and reactive ...
Ihiro Endo   +6 more
doaj   +1 more source

Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma

open access: yesCase Reports in Nephrology, 2022
Malignant pleural mesothelioma is rarely associated with nephrotic syndrome. Cryoglobulinemia is found in various pathological statuses, such as hepatitis C virus infection but rarely in malignant neoplasms.
Kei Nagai   +3 more
doaj   +1 more source

Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis

open access: yesFrontiers in Oncology, 2022
Malignant pleural mesothelioma is an uncommon aggressive tumor. Its incidence is even lower when the lung parenchyma is the primary site. Myositis is a common paraneoplastic syndrome, but it rarely presents with malignant pleural mesothelioma.
Dandan Gong, Jian Yu, Xiaodong Jiang
doaj   +1 more source

Malignant Peritoneal Mesothelioma With EWSR1-ATF1 Fusion: A Case Report

open access: yesJTO Clinical and Research Reports, 2021
Malignant mesothelioma with EWSR1-ATF1 fusion is a rare malignancy described in young adults without asbestos exposure. To the best of our knowledge, outcomes to local and systemic therapies for this subtype of malignant mesothelioma have not been ...
Helen Ke, MBBS (Hons)   +8 more
doaj   +1 more source

The role of CD24 as a potential biomarker for malignant pleural mesothelioma

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2023
Objectives Pleural mesothelioma is a rapidly progressing pleural neoplasm caused by asbestos exposure of a long latency around 30-40 years. Patients with mesothelioma are usually diagnosed at a late stage with poor outcomes in terms of morbidity and ...
Mohamed Shaaban Mousa   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy